ATCvet code QG04

ATC codes
G Genito-urinary system and sex hormones
G01 Gynecological antiinfectives and antiseptics
G02 Other gynecologicals
G03 Sex hormones and modulators of the genital system
G04 Urologicals
ATCvet only
QG51 Antiinfectives and antiseptics for intrauterine use
QG52 Products for teats and udder

ATC code G04 Urologicals is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup G04 is part of the anatomical group G Genito-urinary system and sex hormones.[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QG04...[2] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

G04B Urologicals

G04BA Acidifiers

G04BA01 Ammonium chloride
G04BA03 Calcium chloride
QG04BA90 Methionine

G04BC Urinary concrement solvents

QG04BC90 Tiopronin

G04BD Drugs for urinary frequency and incontinence

G04BD01 Emepronium
G04BD02 Flavoxate
G04BD03 Meladrazine
G04BD04 Oxybutynin
G04BD05 Terodiline
G04BD06 Propiverine
G04BD07 Tolterodine
G04BD08 Solifenacin
G04BD09 Trospium
G04BD10 Darifenacin
G04BD11 Fesoterodine
G04BD12 Mirabegron

G04BE Drugs used in erectile dysfunction

G04BE01 Alprostadil
G04BE02 Papaverine
G04BE03 Sildenafil
G04BE04 Yohimbin
G04BE06 Moxisylyte
G04BE07 Apomorphine
G04BE08 Tadalafil
G04BE09 Vardenafil
G04BE30 Combinations
G04BE52 Papaverine, combinations

QG04BQ Urinary alkalizers

QG04BQ01 Sodium bicarbonate

G04BX Other urologicals

G04BX01 Magnesium hydroxide
G04BX03 Acetohydroxamic acid
G04BX06 Phenazopyridine
G04BX10 Succinimide
G04BX11 Collagen
G04BX12 Phenyl salicylate
G04BX13 Dimethyl sulfoxide
G04BX14 Dapoxetine
G04BX15 Pentosan polysulfate sodium
QG04BX56 Phenazopyridine, combinations
QG04BX90 Ephedrine
QG04BX91 Phenylpropanolamine

G04C Drugs used in benign prostatic hypertrophy

G04CA Alpha-adrenoreceptor antagonists

G04CA01 Alfuzosin
G04CA02 Tamsulosin
G04CA03 Terazosin
G04CA04 Silodosin
G04CA51 Alfuzosin and finasteride
G04CA52 Tamsulosin and dutasteride
G04CA53 Tamsulosin and solifenacin

G04CB Testosterone-5-alpha reductase inhibitors

G04CB01 Finasteride
G04CB02 Dutasteride

G04CX Other drugs used in benign prostatic hypertrophy

G04CX01 Prunus africanae cortex
G04CX02 Sabalis serrulatae fructus
G04CX03 Mepartricin
QG04CX90 Osaterone


This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.